NCT04937621

Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 196 (actual)
• Sponsor: University Hospital, Bordeaux · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cardiac involvement has been described in Severe Acute Respiratory Syndrome - Coronavirus-2 (SARS-CoV-2) infection. Although there are no approved drugs to prevent or treat SARS-CoV-2 infection at present time, several medications used have the potential to increase QT interval and eventually provoke torsades de pointe. The investigators therefore create a study that include all patients with SARS-CoV-2 infection having an electrocardiogram (ECG). The investigators evaluate the percentage of patients with ECG abnormalities, describe the abnormalities and evaluate the occurrence of syncope, ventricular arrhythmia and corrected QT (cQT) interval modification in patients receiving treatment.

Detailed description

In patients with SARS-CoV-2 infection, the investigators analyze baseline ECG as well as follow-up ECG. Patients followed by Bordeaux University Hospital for COVID-19 can be included. ECG are digitized in the computerized patient file (DxCARE) for further analysis.

Conditions

• Arrhythmia
• SARS-CoV-2 Infection

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	ECG data analysis	Baseline ECG as well as follow-up ECG are analysed
DRUG	Treatment data collect	Baseline treatment data as well as follow-up treatment data are collected
BIOLOGICAL	Biological check-up data collect	Baseline Biological check-up data as well as follow-up data are collected
OTHER	Collection of clinical events of interest	Clinical events of interest at the baseline as well as follow-up clinical events are collected

Timeline

• Start date: 2020-06-02
• Primary completion: 2020-12-02
• Completion: 2020-12-31
• First posted: 2021-06-24
• Last updated: 2021-06-24

Locations

1 site across 1 country: France